Friday, Mar 22 2019 8:30 AM full issue Economists say that part of the reason price transparency won’t do much to the market is not only because consumers don’t pay list prices but they also don’t really choose which medication they’re buying. And, unlike with toothpaste or soda, it’s not easy for a consumer to switch brands of medicine. In other pharmaceutical news: pharmacy benefits managers will have their day getting grilled by lawmakers, how the NAFTA deal may hinge on intellectual property protections for pharma products, and more. NPR: How Best To Bring Down Prescription Drug Prices? The Hill: Senate Panel To Hear From Pharmacy Middlemen On Drug Prices The New York Times: Drug Company Protections Are Latest Stumbling Block For Nafta Rewrite Reuters: Kentucky Launches Probe Into Drug Overcharges By Pharmacy Benefit Managers Chicago Tribune: ‘It’s A Struggle To Pay The Bills’: Illinois Independent Pharmacies Say They’re Being Squeezed By Middlemen This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.